Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Patients who take a close look at medical science in search of treatments are often appalled by what they discover. On the one hand, there's academic research, a self-contained and self-absorbed universe of its own where data may be internally consistent (on a good day) and robustly reproducible, yet often has little relevance to real-world clinical conditions.
AEI scholar and psychiatrist Sally Satel explains the number of problems with current PTSD treatments and proposes methods to optimize the use of PTSD funding.
Abstract
Increased donated and subsidised medicines for malaria are saving countless lives in Africa, but there is probably increasing theft and diversion of those medicines. The impact of medicine diversion is unknown but potentially dangerous and may bolster criminal networks and increase medicine stock outs (1,2). This study demonstrates...
How much are medical costs rising because of increased prices?
Scott Gottlieb reviews Eric Topol's book on how medical innovation will coalesce to change clinical practice and what the coming changes mean for today's policy debates.
Think the contraception decision was bad? Wait until bureaucrats start telling your insurer which cancer screenings to cover.
Under the Obama healthcare plan, Medicine is undergoing industrialization as doctors become owned commodities of large hospitals and health plans.
Every day patients receive treatments that do not work properly. For many this means no relief from symptoms, but for some death is the result. Yet concerted action against such products is limited. Before we can discuss why that's the case, I will attempt to explain what kind of products don’t work, and what we should call them.







